Free Review Articles on Anticoagulants                                 Metatextbook

Freie Reviews über Antikoagulantien                                 Look here for Journal Homepages

  • Anticoagulants
  • Premedication and perioperative medicine
  • Anticoagulants (Coumarins Phenprocoumon Warfarin)
  • Heart (Atrial fibrillation)
  • Dabigatran
  • Atherosclerosis (BASKET)
  • Osteocalcin
  • Thrombosis (BASKET)
  • Apixaban
  • Factor IXa (Coagulation)
  • Rivaroxaban
  • Factor VII (Coagulation)
  • Tissue factor
  • Platelets (Therapeutic Inhibitors)
  • Heart valve (Artificial)
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    11994Hereditary warfarin resistance.



    		+-nlSouth Med J 87(3):407-9 (1994)
    22007Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review.



    		+-nlQJM 100(10):599-607 (2007) Hughes M
    32002Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.



    		+-nlQJM 95(7):451-9 (2002) Lip GY
    42006Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.



    		+-nlArch Intern Med 166(4):391-7 (2006) Dezee KJ
    52005Systematic overview of warfarin and its drug and food interactions.



    		+-nlArch Intern Med 165(10):1095-106 (2005) Holbrook AM
    61998Comparing different routes and doses of phytonadione for reversing excessive anticoagulation.



    		+-nlArch Intern Med 158(19):2136-40 (1998)
    72002Thrombin generation and its inhibition: a review of the scientific basis and mechanism of action of anticoagulant therapies.



    		+-nlBr J Anaesth 88(6):848-63 (2002)
    82008Perioperative hemostatic management of patients treated with vitamin K antagonists.



    		+-nlAnesthesiology 109(5):918-26 (2008)
    92009Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy.



    		+-nlInt J Emerg Med 2(4):217-25 (2009) Wojcik C
    102010Reversal of vitamin K antagonists prior to urgent surgery.



    		+-nlCan J Anaesth 57(5):458-67 (2010) Grobler C
    112006Perioperative management of patients receiving vitamin K antagonists.



    		+-nlCan J Anaesth 53(6 Suppl):S113-22 (2006) Ickx BE
    122010Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?



    		+-nlCardiovasc Ther 28(5):295-301 (2010) Escobar C
    132010New antithrombotics for atrial fibrillation.



    		+-nlCardiovasc Ther 28(5):278-86 (2010) Bereznicki LR
    142008Emergence of new oral antithrombotics: a critical appraisal of their clinical potential.



    		+-nlVasc Health Risk Manag 4(6):1373-86 (2008) Lassen MR
    152008Future innovations in anti-platelet therapies.



    		+-nlBr J Pharmacol 154(5):918-39 (2008) Barrett NE
    162006Antiplatelet drugs.



    		+-nlBr J Pharmacol 147 Suppl 1():S241-51 (2006) Born G
    172005New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin.



    		+-nlBr J Pharmacol 144(8):1017-28 (2005) Bates SM
    182008[Natural and synthetic glycosaminoglycans. Molecular characteristics as the basis of distinct drug profiles].



    		+-nlHamostaseologie 28(1-2):51-61 (2008) Alban S
    192005New anticoagulants.



    		+-nlJ Thromb Haemost 3(8):1843-53 (2005) Weitz JI
    201997Correction of excessive anticoagulation with low-dose oral vitamin K1.



    		+-nlAnn Intern Med 126(12):959-62 (1997)
    212008Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents.



    		+-nlBlood 111(10):4871-9 (2008) Crowther MA
    222008Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based.



    		+-nlBlood 111(9):4471-6 (2008) Levi M
    232005New anticoagulants.



    		+-nlBlood 105(2):453-63 (2005) Hirsh J
    242008Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).



    		+-nlChest 133(6 Suppl):257S-298S (2008) Schulman S
    252008Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).



    		+-nlChest 133(6 Suppl):160S-198S (2008) Ansell J
    261998Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.



    		+-nlChest 114(5 Suppl):445S-469S (1998)
    272007Conundrums in the combined use of anticoagulants and antiplatelet drugs.



    		+-nlCirculation 116(3):305-15 (2007) Schneider DJ
    282008Vitamin K-dependent proteins, warfarin, and vascular calcification.



    		+-nlClin J Am Soc Nephrol 3(5):1504-10 (2008) Danziger J
    292007Anticoagulants in heart disease: current status and perspectives.



    		+-nlEur Heart J 28(7):880-913 (2007) De Caterina R
    302006Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.



    		+-nlEur Heart J 27(5):519-26 (2006) Andreotti F
    312008Management of excessive anticoagulant effect due to vitamin K antagonists.



    		+-nlHematology Am Soc Hematol Educ Program ():266-70 (2008) Dentali F
    322008New anticoagulants in children.



    		+-nlHematology Am Soc Hematol Educ Program ():245-50 (2008) Young G
    332004Thrombophilia and new anticoagulant drugs.



    		+-nlHematology Am Soc Hematol Educ Program -(-):424-38 (2004)
    342001Anticoagulation therapy.



    		+-nlHematology Am Soc Hematol Educ Program -(-):339-57 (2001)
    352008Perioperative management of warfarin therapy: to bridge or not to bridge, that is the question.



    		+-nlMayo Clin Proc 83(6):628-9 (2008) Douketis JD
    361989Long-term anticoagulation. Indications and management.



    		+-nlWest J Med 151(4):414-29 (1989)
    372008'Triple therapy' or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents.



    		+-nlJ Am Coll Cardiol 51(8):826-7 (2008) Francescone S
    382008Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.



    		+-nlJ Am Coll Cardiol 51(8):818-25 (2008) Ruiz-Nodar JM
    392003ABC of antithrombotic therapy: Antithrombotic therapy in special circumstances. II-In children, thrombophilia, and miscellaneous conditions.



    		+-nlBMJ 326(7380):93-6 (2003)
    402009An algorithm for managing warfarin resistance.



    		+-nlCleve Clin J Med 76(12):724-30 (2009)
    412003When patients on warfarin need surgery.



    		+-nlCleve Clin J Med 70(11):973-84 (2003)
    422008Should patients on long-term warfarin take aspirin for heart disease?



    		+-nlCleve Clin J Med 75(3):206-8 (2008)
    432011Association between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review.



    		+-nlMayo Clin Proc 86(6):509-21 (2011)
    442010New anticoagulants.



    		+-nlCirculation 121(13):1523-32 (2010)
    452004New anticoagulants for treatment of venous thromboembolism.



    		+-nlCirculation 110(9 Suppl 1):I19-26 (2004)
    462010Combination antithrombotic therapies.



    		+-nlCirculation 121(4):569-83 (2010)
    472011Safety and efficacy of the oral direct factor xa inhibitor apixaban in Japanese patients with non-valvular atrial fibrillation. -The ARISTOTLE-J study-.



    		+-nlCirc J 75(8):1852-9 (2011)
    482011Thrombin inhibitor or factor xa inhibitor? -Opening of a New Era of antithrombotic management-.



    		+-nlCirc J 75(8):1819-20 (2011) Atarashi H
    492011Antithrombotic therapy in atrial fibrillation: evaluation and positioning of new oral anticoagulant agents.



    		+-nlCirc J 75(7):1539-47 (2011)
    502010Antithrombotic therapy. ESC guidelines vs JCS guidelines.



    		+-nlCirc J 74(12):2542-5 (2010)
    512010Coagulation factor IXa as a target for treatment and prophylaxis of venous thromboembolism.



    		+-nlArterioscler Thromb Vasc Biol 30(3):382-7 (2010) Eikelboom JW
    522010Rivaroxaban: a new oral factor Xa inhibitor.



    		+-nlArterioscler Thromb Vasc Biol 30(3):376-81 (2010) Perzborn E
    532010Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin.



    		+-nlArterioscler Thromb Vasc Biol 30(10):1885-9 (2010)
    542007Inhibitors of Factor VIIa/tissue factor.



    		+-nlArterioscler Thromb Vasc Biol 27(9):1895-900 (2007)
    552009New antithrombotic agents: are they needed and what can they offer to patients with a non-ST-elevation acute coronary syndrome?



    		+-nlEur Heart J 30(14):1695-702 (2009)
    562007Oral anticoagulant therapy. Fundamentals, clinical practice and recommendations.



    		+-nlRev Port Cardiol 26(7-8):769-88 (2007)
    572008The debate concerning oral anticoagulation: whether to suspend oral anticoagulants during dental treatment.



    		+-nlRev Port Cardiol 27(4):531-44 (2008)
    582010The new oral anticoagulants.



    		+-nlBlood 115(1):15-20 (2010)
    592009Oral anticoagulation with Factor Xa and thrombin inhibitors: Is there an alternative to warfarin?



    		+-nlDiscov Med 8(43):196-203 (2009)
    602009Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage - from theory to practice.



    		+-nlCrit Care 13(2):209 (2009)
    612010Emergency reversal of warfarin anticoagulation.



    		+-nlCMAJ 182(18):2004 (2010)
    622007What is the optimal level of anticoagulation in adult patients receiving warfarin following implantation of a mechanical prosthetic mitral valve?



    		+-nlInteract Cardiovasc Thorac Surg 6(3):390-6 (2007)
    632010New options with dabigatran etexilate in anticoagulant therapy.



    		+-nlVasc Health Risk Manag 6(-):339-49 (2010)
    642010Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management.



    		+-nlNeth J Med 68(2):68-76 (2010)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.